A dual GLP-1 and glucagon agonist developed by Altimmune has been shown to reduce drinking in people with alcohol use ...

AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, the first market for the hair loss ...

A US judge has ordered that Novo Nordisk must face some allegations in court that it defrauded investors by making misleading ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...

Recordati has received an unsolicited takeover offer from private equity group CVC Capital Partners that, if completed, would delist the pharma group from the Italian stock exchange. The €52-per-share ...

France's financial fraud office launched a raid on Sanofi's headquarters in Paris as part of an investigation into a financing deal provided by French bank Société Générale. The Parquet National ...

In a major shake-up of its UK operations, GSK has started building a brand new R&D centre in Cambridge and will transfer operations there from its current site in Stevenage, Hertfordshire, which has ...

Johnson & Johnson has made a $5.5 billion bid to finally bring more than 15 years of litigation over the safety of its talcum powder products to a close. The settlement offer is dependent on 95% of ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya. The shot protects ...

Bavarian Nordic has repeated a recommendation that its shareholders accept a takeover offer from an investment consortium, saying updated terms are "fair and attractive." The Danish biopharma company ...

The US federal government has named the next 15 medicines that will be subject to Medicare pricing negotiation and reductions due to come into effect at the start of 2028. The list has been announced ...

Scribe Therapeutics has become the latest biotech to list on the Nasdaq in the US, raising more than $155 million to advance ...